Related Experiment Video

Updated: Aug 14, 2026

Assessing Specificity of Anticancer Drugs In Vitro
09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

[Renal cancer study activities in Germany. Drug therapy]

D Rohde1

  • 1Urologische Klinik des Klinikums Darmstadt, Akademisches Lehrkrankenhaus der Universität Frankfurt a.M., Darmstadt. detlef.rohde@klinikum-darmstadt.de

Der Urologe. Ausg. A
|November 15, 2005
PubMed

Insights

Recent advances in targeted drug combinations for advanced renal cell carcinoma show promising results. This review highlights German clinical study activities and future directions in renal cell carcinoma treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Nephrology

Context:

  • Advanced renal cell carcinoma (RCC) treatment landscape is evolving rapidly.
  • Global clinical studies have focused on monotherapy and targeted drug combinations.
  • Pharmaceutical industry support has facilitated swift patient enrollment in trials.

Purpose:

  • To review recent drug study activities in Germany for advanced RCC.
  • To outline potential future research projects in advanced RCC therapy.

Summary:

  • The past two years have seen a shift towards combination targeted drug therapies for advanced RCC.
  • Preliminary results from these studies are encouraging.
  • German investigators are actively participating in and contributing to these global efforts.

Impact:

  • Provides an overview of current and future therapeutic strategies for advanced RCC.
  • Informs clinicians and researchers about the latest developments in RCC drug therapy.
  • Highlights the role of German research in advancing RCC treatment globally.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...